Literature DB >> 20001286

Tolerance and sensitization to the effects of cocaine use in humans: a retrospective study of long-term cocaine users in Philadelphia.

A C Small1, K M Kampman, J Plebani, M De Jesus Quinn, L Peoples, K G Lynch.   

Abstract

In the effort to develop medications to combat addiction, researchers have developed models that attempt to describe the neurobiological process of cocaine dependence. It has not, however, yet been determined which of these models, if any, best fits the behaviors and experiences of patients. This project retrospectively evaluated changes in patients' experiences with cocaine over time in order to clarify the model that best fits clinical observations. In 2005 and 2007, 100 treatment-seeking, long-term cocaine users were recruited from an urban university-based treatment center in Philadelphia, PA, United States. Each participant was administered the "Cocaine History Questionnaire" which asked them to describe the initiation and escalation of their cocaine usage, changing reward perceptions, and effects of intoxication at certain points in their drug use careers. This data was then analyzed using repeated measures, examining the within subject differences in reported information over the time points. We found evidence that while the amount of drug used increases, self-reported euphoria decreases while negative symptoms associated with cocaine use also increase. The data provide preliminary evidence for the hedonic dysregulation model of addiction. Limitations and implications of the study are discussed in the conclusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001286     DOI: 10.3109/10826080902961179

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

1.  The missing variable: ultrasonic vocalizations reveal hidden sensitization and tolerance-like effects during long-term cocaine administration.

Authors:  Esther Y Maier; Mohamed Abdalla; Allison M Ahrens; Timothy Schallert; Christine L Duvauchelle
Journal:  Psychopharmacology (Berl)       Date:  2011-08-26       Impact factor: 4.530

2.  Sex Differences in the Motivational Contrast between Sucrose and Cocaine in Rats.

Authors:  Udita Datta; Mariangela Martini; Wen Lin Sun
Journal:  J Drug Des Res       Date:  2017-03-28

Review 3.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

4.  Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers.

Authors:  N D Volkow; D Tomasi; G-J Wang; J Logan; D L Alexoff; M Jayne; J S Fowler; C Wong; P Yin; C Du
Journal:  Mol Psychiatry       Date:  2014-06-10       Impact factor: 15.992

Review 5.  Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern.

Authors:  Rita Roque Bravo; Ana Carolina Faria; Andreia Machado Brito-da-Costa; Helena Carmo; Přemysl Mladěnka; Diana Dias da Silva; Fernando Remião
Journal:  Toxins (Basel)       Date:  2022-04-13       Impact factor: 5.075

6.  The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats.

Authors:  Colin N Haile; Yanli Hao; Patrick W O'Malley; Thomas F Newton; Therese A Kosten
Journal:  Brain Sci       Date:  2012-11-13

7.  Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances.

Authors:  Florence Vorspan; Romain Icick; Nawel Mekdad; Cindie Courtin; Vanessa Bloch; Frank Bellivier; Jean-Louis Laplanche; Nathalie Prince; Dmitry Pishalin; Cyril Firmo; Corinne Blugeon; Bruno Mégarbane; Cynthia Marie-Claire; Nadia Benturquia
Journal:  Transl Psychiatry       Date:  2020-11-06       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.